denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Immunotherapy in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Diseases, bioengineering, Therapies, CAR-Ts, Technology and Procedures, immune cells, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, gene editing, Clinically relevant
Session: Immunotherapy in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Diseases, bioengineering, Therapies, CAR-Ts, Technology and Procedures, immune cells, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, gene editing, Clinically relevant
Sunday, December 6, 2020, 9:25 AM-9:30 AM
Disclosures: Smith: Precision Biosciences: Consultancy; Fate Therapeutics: Consultancy; Bristol Myers Squibb: Consultancy, Patents & Royalties, Research Funding.